Clinical Study

miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer

Figure 2

Kaplan-Meier survival curves of GC patients. The overall survival rate in patients with high miR-21 expression was significantly lower than that in those with low miR-21 expression ( ).
640168.fig.002